Study finds reliable performance for wireless pacemaker

A dual-chamber wireless pacemaker provides reliable performance over three months, bolstering evidence for this new option, according to results from a multi-center international clinical trial co-led by a Weill Cornell Medicine investigator.

Economists uncover hidden influence of top campaign donors

The death of a top donor during an electoral cycle decreases the likelihood that a candidate will be elected by more than three percentage points, according to an innovative new study by Cornell economists and colleagues.

Preclinical study explores approved drug for ovarian cancer

An iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian tumors, according to a new study led by Weill Cornell Medicine researchers.

Medicaid enrollees struggle to find psychiatric care

Many people enrolled in Medicaid who require psychiatric care have difficulty accessing clinicians in a timely manner despite the higher need in this population, according to a study by researchers at Weill Cornell Medicine.

Acceptance seen as a key to ‘financial mindfulness’

Emily Garbinsky, of the Johnson School, and colleagues have proposed an eight-item scale to measure individual differences in financial mindfulness, incorporating elements of both awareness and acceptance of one's financial situation.

Medicaid policies increase diversity in cancer clinical trials

Two Medicaid policies can interact to increase oncology clinical trial enrollment among Black and Hispanic patients, according to a new study by investigators at Weill Cornell Medicine, the University of Pennsylvania and Medidata AI.

Nexus Scholars study climate change inequality and infant language learning

The program in the College of Arts & Sciences provides undergraduate students with summer opportunities to conduct research with and be mentored by faculty from across the college.

Around Cornell

Blood test may guide use of multiple myeloma immunotherapy

A simple blood test that measures the number of lymphocytes may predict whether people who have relapsed multiple myeloma are going to respond well to CAR-T immunotherapy.

Model offers insights into Parkinson’s disease process

A new preclinical model offers a unique platform for studying the Parkinson’s disease process and suggests a relatively easy method for detecting the disease.